These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 24747439)

  • 21. Loss of the urothelial differentiation marker FOXA1 is associated with high grade, late stage bladder cancer and increased tumor proliferation.
    DeGraff DJ; Clark PE; Cates JM; Yamashita H; Robinson VL; Yu X; Smolkin ME; Chang SS; Cookson MS; Herrick MK; Shariat SF; Steinberg GD; Frierson HF; Wu XR; Theodorescu D; Matusik RJ
    PLoS One; 2012; 7(5):e36669. PubMed ID: 22590586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urothelium-specific expression of an oncogene in transgenic mice induced the formation of carcinoma in situ and invasive transitional cell carcinoma.
    Zhang ZT; Pak J; Shapiro E; Sun TT; Wu XR
    Cancer Res; 1999 Jul; 59(14):3512-7. PubMed ID: 10416618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetic regulation of mammalian Hedgehog signaling to the stroma determines the molecular subtype of bladder cancer.
    Kim S; Kim Y; Kong J; Kim E; Choi JH; Yuk HD; Lee H; Kim HR; Lee KH; Kang M; Roe JS; Moon KC; Kim S; Ku JH; Shin K
    Elife; 2019 Apr; 8():. PubMed ID: 31036156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of genetic alterations in normal bladder urothelium.
    Leonardo C; Gallucci M; Cianciulli AM
    Urology; 2004 Aug; 64(2):405; author reply 405-6. PubMed ID: 15302516
    [No Abstract]   [Full Text] [Related]  

  • 25. Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic Implications.
    Hovelson DH; Udager AM; McDaniel AS; Grivas P; Palmbos P; Tamura S; Lazo de la Vega L; Palapattu G; Veeneman B; El-Sawy L; Sadis SE; Morgan TM; Montgomery JS; Weizer AZ; Day KC; Neamati N; Liebert M; Keller ET; Day ML; Mehra R; Tomlins SA
    Eur Urol; 2018 Dec; 74(6):741-753. PubMed ID: 30033047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of Nectin-4 in Bladder Urothelial Carcinoma, in Morphologic Variants, and Nonurothelial Histotypes.
    Hoffman-Censits JH; Lombardo KA; Parimi V; Kamanda S; Choi W; Hahn NM; McConkey DJ; McGuire BM; Bivalacqua TJ; Kates M; Matoso A
    Appl Immunohistochem Mol Morphol; 2021 Sep; 29(8):619-625. PubMed ID: 33901032
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ethanol-extracted propolis enhances BBN-initiated urinary bladder carcinogenesis via non-mutagenic mechanisms in rats.
    Xie XL; Gi M; Fujioka M; Doi K; Yamano S; Tachibana H; Fang H; Kakehashi A; Wanibuchi H
    Food Chem Toxicol; 2015 Sep; 83():193-200. PubMed ID: 26111810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conditional Expression of the Androgen Receptor Increases Susceptibility of Bladder Cancer in Mice.
    Johnson DT; Hooker E; Luong R; Yu EJ; He Y; Gonzalgo ML; Sun Z
    PLoS One; 2016; 11(2):e0148851. PubMed ID: 26862755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A genetically defined disease model reveals that urothelial cells can initiate divergent bladder cancer phenotypes.
    Wang L; Smith BA; Balanis NG; Tsai BL; Nguyen K; Cheng MW; Obusan MB; Esedebe FN; Patel SJ; Zhang H; Clark PM; Sisk AE; Said JW; Huang J; Graeber TG; Witte ON; Chin AI; Park JW
    Proc Natl Acad Sci U S A; 2020 Jan; 117(1):563-572. PubMed ID: 31871155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Smoothelin immunohistochemistry is a useful adjunct for assessing muscularis propria invasion in bladder carcinoma.
    Bovio IM; Al-Quran SZ; Rosser CJ; Algood CB; Drew PA; Allan RW
    Histopathology; 2010 Jun; 56(7):951-6. PubMed ID: 20636795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RGS6 is an essential tumor suppressor that prevents bladder carcinogenesis by promoting p53 activation and DNMT1 downregulation.
    Yang J; Platt LT; Maity B; Ahlers KE; Luo Z; Lin Z; Chakravarti B; Ibeawuchi SR; Askeland RW; Bondaruk J; Czerniak BA; Fisher RA
    Oncotarget; 2016 Oct; 7(43):69159-69172. PubMed ID: 27713144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Grainyhead-Like 3 Influences Migration and Invasion of Urothelial Carcinoma Cells.
    Wezel F; Lustig J; Azoitei A; Liu J; Meessen S; Najjar G; Zehe V; Faustmann P; Zengerling F; John A; Martini T; Bolenz C; Günes C
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33803949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High expression of Notch ligand Jagged2 is associated with the metastasis and recurrence in urothelial carcinoma of bladder.
    Li W; Liu M; Feng Y; Huang YF; Xu YF; Che JP; Wang GC; Zheng JH
    Int J Clin Exp Pathol; 2013; 6(11):2430-40. PubMed ID: 24228105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytogenetic characterization of an N-butyl-N-(4-hydroxybutyl) nitrosamine-induced mouse papillary urothelial carcinoma.
    Arantes-Rodrigues R; Pinto-Leite R; da Costa RG; Colaço A; Lopes C; Oliveira P
    Tumour Biol; 2013 Oct; 34(5):2691-6. PubMed ID: 23645214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular pathways of urothelial development and bladder tumorigenesis.
    Castillo-Martin M; Domingo-Domenech J; Karni-Schmidt O; Matos T; Cordon-Cardo C
    Urol Oncol; 2010; 28(4):401-8. PubMed ID: 20610278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PAK5 mediates cell: cell adhesion integrity via interaction with E-cadherin in bladder cancer cells.
    Ismail AF; Oskay Halacli S; Babteen N; De Piano M; Martin TA; Jiang WG; Khan MS; Dasgupta P; Wells CM
    Biochem J; 2017 Mar; 474(8):1333-1346. PubMed ID: 28232500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. E-cadherin expression during urothelial carcinogenesis induced by N-butyl-N-(4-hydroxybutyl) nitrosamine in rats.
    Oliveira PA; Colaço A; De la Cruz LF; Lopes P; Lopes C
    J Exp Clin Cancer Res; 2006 Sep; 25(3):425-32. PubMed ID: 17167984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urothelial tumors of the urinary bladder in young patients: a clinicopathologic study of 59 cases.
    Stanton ML; Xiao L; Czerniak BA; Guo CC
    Arch Pathol Lab Med; 2013 Oct; 137(10):1337-41. PubMed ID: 24079760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stem cell marker-positive stellate cells and mast cells are reduced in benign-appearing bladder tissue in patients with urothelial carcinoma.
    Isfoss BL; Busch C; Hermelin H; Vermedal AT; Kile M; Braathen GJ; Majak B; Berner A
    Virchows Arch; 2014 Apr; 464(4):473-88. PubMed ID: 24570393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sequential changes of mouse bladder epithelium during induction of invasive carcinomas by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Ohtani M; Kakizoe T; Nishio Y; Sato S; Sugimura T; Fukushima S; Niijima T
    Cancer Res; 1986 Apr; 46(4 Pt 2):2001-4. PubMed ID: 3948177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.